Bristol Myers Squibb Bolsters Pipeline with Two Multibillion-Dollar Acquisitions
By Lucy Haggerty
Pharma Deals Review: Vol 2024 Issue 1 (Table of Contents)
Published: 11 Jan-2024
DOI: 10.3833/pdr.v2024.i1.2847 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Finishing 2023 with a bang, Bristol Myers Squibb (BMS) announced its planned acquisitions of both Karuna Therapeutics and RayzeBio in quick succession of one another...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS